Indegene buys BioPharm for $106 million to boost AI-driven pharma marketing

The Omnicom Health Group company’s acquisition will help the Indian firm’s adtech capabilities at a time of increasing disruption in the pharmaceutical sector.

by Campaign India Team

To continue enjoying this content, please sign in below. You can register for free for limited further access or subscribe now for full access to all out content.

Sign In

Trouble signing in?

Reset Password: Click here

Contact Customer Support at

campaignindia.support@haymarket.co.in

Register for free

✓ Access limited free articles each month

✓ Email bulletins – top industry news and insights delivered straight to your inbox

✓ All the latest local and global industry news

✓ The most inspirational and innovative campaigns

✓ Interviews and opinion from leading industry figures

Subscribe now